Skip to Content
Søk Menu

EHA 2019: Highly effective combination for initial therapy for young, fit CLL patients

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Tereza Faitova

Gut microbiome dysbiosis could be implicated in the pathogenesis of CLL

/ Tereza Faitova
KLLEHA22 Play the Video 5:04
Matthew S. Davids

ReVenG: Retreatment with venetoclax plus obinutuzumab in patients with relapsed CLL

/ Matthew S. Davids
KLLASH21 Play the Video 2:37
Paolo Ghia

How can we use Minimal Residual Disease in the treatment of CLL?

/ Paolo Ghia
KLLASH21 Play the Video 2:03
Back to top